LipimetiX Development Announces Sub-License of APO E Mimetic Peptide Platform to Anji Pharma, China
May 7, 2018
by Barbara Dunford
Comments Off on Press Release May 7, 2018 – 09:00 ET
May 7, 2018
by Barbara Dunford
Comments Off on Press Release May 7, 2018 – 09:00 ET
LipimetiX Development Announces Sub-License of APO E Mimetic Peptide Platform to Anji Pharma, China
July 17, 2017
by Barbara Dunford
Comments Off on Press Release July 17, 2017 – 09:00 ET
CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION FOR SALE OF SHARES OF ITS COMMON STOCK and SECURED LOAN